SOMANYCERA Q1 FY27 Guidance vs Delivery (SOMANYCERA Management Mirror)

Q1 FY27 EBITDA Margin Reported at 11.5%, Outperforming Base Target; Future Quarters Guided Above 12% on Capacity Additions

In the Dec'25 Qtr concall, management expected EBITDA margins to improve by 1% to 1.5% in Q4'26. In the Mar'26 Qtr concall, management reported Q4'FY26 EBITDA margin at 11.4% and the FY26 margin at 9.3%. Management initiated FY27 guidance to improve EBITDA margins by at least 150 bps or more over the FY26 base of 9.3%. In the Jun'26 Qtr concall, management stated Q1 FY27 EBITDA margins increased 3.6% YoY to 11.6%; the Jun'26 Qtr Quarterly Financial Results reported EBITDA Margin at 11.5% (+353 bps YoY). Management remains confident of maintaining the 11%-plus margins delivered in Q1 FY27 and is actively targeting to exceed 12% in future quarters as value-added capacity changes unfold in Q3 FY27 and Q4 FY27.